Inogen | INGN - Debt


Inogen reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.78M 1.6M Mar/2026
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Medtronic USD 28.15B 192M Jun/2026
Orthofix International USD 137.23M 338K Sep/2024
Philips EUR 7.47B 632M Jun/2026
ResMed USD 843.17M 4.55M Mar/2026
Steris USD 2.09B 33.5M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
X T L Biopharmaceuticals USD 269K 131K Dec/2025
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026